Monopar Therapeutics (MNPR) Institutional Shareholders
Monopar Therapeutics (MNPR) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $525.65M in MNPR holdings during the latest filing period.
Janus Henderson Group Plc is currently the largest disclosed institutional shareholder of MNPR tracked by InsiderSet, reporting ownership valued at approximately $72.06M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $127.09M, representing an estimated gain of +76.36% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 63% of the total disclosed MNPR value among the investors covered in this analysis. Major shareholders include Janus Henderson Group Plc, Ra Capital Management, L.P., Blackrock, Inc., and several other long-term asset managers with concentrated positions in Monopar Therapeutics (MNPR).
This page ranks the largest institutional MNPR shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
93
Total Reported Value
$525.65M
Largest Holder
Janus Henderson Group Plc
Largest Position
$72.06M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
116
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Janus Henderson Group Plc | 0.04% | 1,317,410 | $72,062,327 | $127,090,543 | +$55,028,216 | +76.36% | |
| Ra Capital Management, L.P. | 0.54% | 667,207 | $61,776,696 | $64,365,459 | +$2,588,763 | +4.19% | |
| Blackrock, Inc. | 0.00% | 348,819 | $32,297,151 | $33,650,569 | +$1,353,418 | +4.19% | |
| Deerfield Management Company, L.P. | 0.31% | 323,745 | $29,975,550 | $31,231,680 | +$1,256,130 | +4.19% | |
| Saturn V Capital Management Lp | 4.14% | 311,976 | $28,885,858 | $30,096,325 | +$1,210,467 | +4.19% | |
| Siren, L.L.C. | 0.51% | 270,118 | $25,010,226 | $26,058,283 | +$1,048,057 | +4.19% | |
| Adar1 Capital Management, Llc | 0.95% | 217,595 | $20,147,121 | $20,991,390 | +$844,269 | +4.19% | |
| Polar Capital Holdings Plc | 0.06% | 214,469 | $19,857,685 | $20,689,824 | +$832,139 | +4.19% | |
| Vanguard Capital Management Llc | 0.00% | 209,711 | $19,417,141 | $20,230,820 | +$813,679 | +4.19% | |
| Adage Capital Partners Gp, L.L.C. | 0.03% | 209,195 | $19,369,365 | $20,181,042 | +$811,677 | +4.19% | |
| Tcg Crossover Management, Llc | 0.45% | 203,327 | $18,826,047 | $19,614,956 | +$788,909 | +4.19% | |
| Wellington Management Group Llp | 0.00% | 158,437 | $14,669,682 | $15,284,417 | +$614,735 | +4.19% | |
| Orbimed Advisors Llc | 0.28% | 157,423 | $14,575,796 | $15,186,597 | +$610,801 | +4.19% | |
| Candriam S.C.A. | 0.06% | 143,339 | $13,258,989 | $13,827,913 | +$568,924 | +4.29% | |
| Balyasny Asset Management L.P. | 0.02% | 134,543 | $12,457,336 | $12,979,363 | +$522,027 | +4.19% | |
| Geode Capital Management, Llc | 0.00% | 112,578 | $10,426,384 | $10,860,400 | +$434,016 | +4.16% | |
| Alyeska Investment Group, L.P. | 0.02% | 100,000 | $9,259,000 | $9,647,000 | +$388,000 | +4.19% | |
| State Street Corp | 0.00% | 92,551 | $8,569,297 | $8,928,395 | +$359,098 | +4.19% | |
| Vivo Capital, Llc | 0.77% | 90,500 | $8,379,395 | $8,730,535 | +$351,140 | +4.19% | |
| Driehaus Capital Management Llc | 0.05% | 84,040 | $7,781,264 | $8,107,339 | +$326,075 | +4.19% | |
| Bank Of New York Mellon Corp | 0.00% | 76,942 | $7,124,057 | $7,422,595 | +$298,538 | +4.19% | |
| Vestal Point Capital, Lp | 0.16% | 75,727 | $7,011,563 | $7,305,384 | +$293,821 | +4.19% | |
| Longaeva Partners L.P. | 0.15% | 55,834 | $5,169,670 | $5,386,306 | +$216,636 | +4.19% | |
| Neuberger Berman Group Llc | 0.00% | 55,194 | $5,110,413 | $5,324,565 | +$214,152 | +4.19% | |
| Millennium Management Llc | 0.00% | 50,311 | $4,658,295 | $4,853,502 | +$195,207 | +4.19% | |
| Vanguard Portfolio Management Llc | 0.00% | 48,816 | $4,519,873 | $4,709,280 | +$189,407 | +4.19% | |
| Ikarian Capital, Llc | 0.73% | 47,861 | $4,431,450 | $4,617,151 | +$185,701 | +4.19% | |
| Citadel Advisors Llc | 0.00% | 37,004 | $3,426,200 | $3,569,776 | +$143,576 | +4.19% | |
| Northern Trust Corp | 0.00% | 34,641 | $3,207,411 | $3,341,817 | +$134,406 | +4.19% | |
| Deutsche Bank Ag\ | 0.00% | 31,008 | $2,871,031 | $2,991,342 | +$120,311 | +4.19% | |
| Stempoint Capital Lp | 0.48% | 30,125 | $2,789,274 | $2,906,159 | +$116,885 | +4.19% | |
| Vanguard Fiduciary Trust Co | 0.00% | 28,280 | $2,618,445 | $2,728,172 | +$109,727 | +4.19% | |
| Ubs Group Ag | 0.00% | 27,259 | $2,523,911 | $2,629,676 | +$105,765 | +4.19% | |
| Morgan Stanley | 0.00% | 17,919 | $1,659,121 | $1,728,646 | +$69,525 | +4.19% | |
| Ameriprise Financial Inc | 0.00% | 17,800 | $1,648,102 | $1,717,166 | +$69,064 | +4.19% | |
| Goldman Sachs Group Inc | 0.00% | 16,161 | $1,496,347 | $1,559,052 | +$62,705 | +4.19% | |
| Russell Investments Group, Ltd. | 0.00% | 14,850 | $1,374,961 | $1,432,580 | +$57,619 | +4.19% | |
| Boothbay Fund Management, Llc | 0.03% | 14,689 | $1,360,055 | $1,417,048 | +$56,993 | +4.19% | |
| Charles Schwab Investment Management Inc | 0.00% | 13,953 | $1,291,908 | $1,346,046 | +$54,138 | +4.19% | |
| Ishara Investments Lp | 0.84% | 12,300 | $1,138,857 | $1,186,581 | +$47,724 | +4.19% | |
| Two Sigma Investments, Lp | 0.00% | 12,252 | $1,134,413 | $1,181,950 | +$47,537 | +4.19% | |
| Trexquant Investment Lp | 0.01% | 12,004 | $1,111,450 | $1,158,026 | +$46,576 | +4.19% | |
| Gsa Capital Partners Llp | 0.04% | 7,532 | $697,000 | $726,612 | +$29,612 | +4.25% | |
| Xtx Topco Ltd | 0.01% | 6,536 | $605,168 | $630,528 | +$25,360 | +4.19% | |
| Nuveen, Llc | 0.00% | 5,980 | $553,688 | $576,891 | +$23,203 | +4.19% | |
| Barclays Plc | 0.00% | 5,833 | $540,077 | $562,710 | +$22,633 | +4.19% | |
| Rhumbline Advisers | 0.00% | 5,630 | $521,271 | $543,126 | +$21,855 | +4.19% | |
| Gerber, Llc | 0.24% | 5,601 | $518,597 | $540,328 | +$21,731 | +4.19% | |
| Raymond James Financial Inc | 0.00% | 5,474 | $506,838 | $528,077 | +$21,239 | +4.19% | |
| Virtus Investment Advisers, Llc | 0.12% | 5,474 | $506,838 | $528,077 | +$21,239 | +4.19% |
Frequently asked questions about MNPR
Who owns the most MNPR stock?
The largest holders of MNPR are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for Monopar Therapeutics (MNPR).
Is MNPR widely held by superinvestors?
Many widely followed stocks like MNPR appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly MNPR is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.